SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?


To: Sonki who wrote (1054)11/24/1998 11:02:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 1580
 
Merck & Co. Reiterated 'Buy' at Gerard Klauer
[Sonki, no news on meeting so far]

Bloomberg News
November 24, 1998, 9:57 a.m. ET

Princeton, New Jersey, Nov. 24 (Bloomberg Data) -- Merck & Co Inc. (MRK
US) was reiterated ''buy'' by analyst Cynthia A. Beach at Gerard Klauer
Mattison & Co. The 12-month target price is $185.00 per share.

-- Colleen Sferra in Princeton, New Jersey, (609)279-3843